Ignite Creation Date:
2024-05-06 @ 7:56 PM
Last Modification Date:
2024-10-26 @ 3:17 PM
Study NCT ID:
NCT06191978
Status:
RECRUITING
Last Update Posted:
2024-07-08
First Post:
2023-12-19
Brief Title:
A Phase IaIb Open-label Multiple Dose Study to Determine the Recommended Dose Evaluate PKs PDs Safety and Activity of Venetoclax in Combination With Oral DecitabineCedazuridine ASTX727 in Pediatric Patients With RelapsedRefractory Acute Myeloid Leukemia AML
Sponsor:
Organization:
MD Anderson Cancer Center
Study Design
Study Type:
INTERVENTIONAL
Expanded Access Type Individual:
None
Expanded Access Type Intermediate:
None
Expanded Access Type Treatment:
None
Patient Registry:
None
Target Duration:
None
Design Allocation:
Design Intervention Model:
Design Intervention Model Description:
Design Masking Description:
Bio Spec Retention:
None
Bio Spec Description:
None
Enrollment Count:
40
Enrollment Type:
ESTIMATED
Design Primary Purpose:
Design Masking:
Phases:
| Name |
|---|
| PHASE1 |
Observational Models:
Time Perspective List:
Who Masked List: